Sponsor or institution
Clinical trials and research at Tasly Pharmaceutical Group Co., Ltd
As of November 12, 2026, Find a Trial lists 9 clinical trials run by Tasly Pharmaceutical Group Co., Ltd that are recruiting, in China. By phase: Phase 3 (5), Phase 1/2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Qishen Yiqi Dripping Pills for Chronic Heart Failure (HFrEF) in adults | Phase 3 | Bozhou, Anhui and 59 other locations | Recruiting | Jul 7, 2026 |
| TSL2109 capsules for advanced solid tumors, including treatment‑resistant prostate cancer | Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Apr 7, 2026 |
| Testing B2065 for safety and early effectiveness in acute ischemic stroke | Phase 1/2 | Beijing | Recruiting | Jan 28, 2026 |
| P134 CAR‑T Cell Therapy for Recurrent Glioblastoma | Phase 1/2 | Beijing | Recruiting | Jan 6, 2026 |
| Intramyocardial umbilical‑cord mesenchymal stem cell injection with CABG for chronic ischemic heart failure | Phase 1/2 | Shanghai, Shanghai Municipality and 3 other locations | Recruiting | Dec 4, 2025 |
| Evaluating Antiwei Granules for treating the common cold | Phase 3 | Beijing and 23 other locations | Recruiting | Nov 20, 2024 |
| Lianxiaxiaopi Granules to treat postprandial distress syndrome | Phase 3 | Beijing, Beijing Municipality and 17 other locations | Recruiting | Nov 20, 2024 |
| Treatment of breast hyperplasia with Xiangjurupining Capsule | Phase 3 | Beijing, Beijing Municipality and 26 other locations | Recruiting | Nov 13, 2024 |
| Comparing Jitongning tablets to placebo for treating spondyloarthritis | Phase 3 | Beijing, Beijing Municipality and 9 other locations | Recruiting | Aug 21, 2023 |
All recruiting trials (9)
-
Qishen Yiqi Dripping Pills for Chronic Heart Failure (HFrEF) in adults
This trial tests whether Qishen Yiqi Dripping Pills can help adults with chronic heart failure and reduced ejection fraction who also have coronary heart disease.
-
TSL2109 capsules for advanced solid tumors, including treatment‑resistant prostate cancer
This trial tests whether the oral drug TSL2109 is safe, tolerable, and shows early signs of benefit for people with advanced solid tumors, especially those with metastatic castration‑resistant prostate cancer who have progressed after standard therapies.
-
Testing B2065 for safety and early effectiveness in acute ischemic stroke
This will test a single IV infusion of B2065 versus placebo in adults 18–75 who have an acute ischemic stroke and can be treated within 36 hours of symptom onset.
-
P134 CAR‑T Cell Therapy for Recurrent Glioblastoma
This study will try P134 CAR‑T cells that target CD44 and CD133 to see if they are safe and can help control tumors in adults with recurrent IDH‑wildtype glioblastoma.
-
Intramyocardial umbilical‑cord mesenchymal stem cell injection with CABG for chronic ischemic heart failure
This trial will test whether injecting umbilical‑cord derived mesenchymal stem cells into the heart at the time of bypass surgery helps people with chronic ischemic heart failure and reduced ejection fraction.
-
Evaluating Antiwei Granules for treating the common cold
This study tests if Antiwei granules can help adults with the common cold feel better compared to a placebo.
-
Lianxiaxiaopi Granules to treat postprandial distress syndrome
This trial will test whether Lianxiaxiaopi Granules can help adults with postprandial distress syndrome reduce post-meal fullness, early satiety, or discomfort.
-
Treatment of breast hyperplasia with Xiangjurupining Capsule
This study is testing if a traditional Chinese medicine called Xiangjurupining Capsule can help women aged 18 to 50 with breast hyperplasia feel better and improve their breast health.
-
Comparing Jitongning tablets to placebo for treating spondyloarthritis
This study is testing if Jitongning tablets can help people with active ankylosing spondylitis feel better compared to a placebo.
Quick answers
How many clinical trials run by Tasly Pharmaceutical Group Co., Ltd are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 5, Phase 1/2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.